Buradasınız

Anasayfa » Content

Güneydoğu Anadolu Bölgesinde Son Dönem Böbrek Yetmezliği Hastalarında ACE Gen Polimorfizmi Prevalansı

Prevalance of ACE Gene Polymorphism in Patients with End Stage Kidney Disease in Southeastern Turkey

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2007

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Aim: To evaluate the frequency of angiotensin converting enzyme gene polymorphism from renin angiotensin aldosterone system in patients undergoing chronic dialysis. Materials and Methods: Eighty-seven patients undergoing dialysis treatment and 38 healthy volunteers were enrolled in the study. Demographic features, arterial blood pressure, body mass index (BMI), hematological and biochemical parameters were recorded. ACE gene polymorphism was studied using sterile polymerase chain reaction (PCR) method from blood samples taken into tubes containing EDTA. Results: Of the 87 patients, 49 were undergoing hemodialysis and 38 were on peritoneal dialysis programme. In the patient group male/female ratio was 48/39 and the mean age was 41.1 ±13.6 years; in controls male/female ratio was 14/24 and the mean age was 38.0+1.41 years. Diabetes mellitus, hypertension, chronic glomerulonephritis were the first three causes of ESRD with percentages of 28, 24, and 23% respectively. Systolic and diastolic blood pressures were higher in patients than controls. ACE gene (l/D) polymorphism prevalence was found as 0.9%, 44.8%, 45.9% among patients, and 31.5%, 39.4%, 28.9% among controls for ll/ID/DD respectively, and statistical significance was found (p=0.006). ACE D allele frequency was 68.4% among patients, and 48.7% among controls (p=0.001). Conclusion: We found difference in dispersion of ACE genotype and frequency of D allele between patients and controls.
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: Diyaliz tedavisi gören hasta popülasyonunda renin an-jiyotensin aldosteron sisteminden, anjîyotensin dönüştürücü enzim gen polimorfizm frekansını değerlendirmektir. Gereç ve Yöntem: Çalışmaya diyaliz tedavisi gören 87 hasta ve kontrol grubu olarak 38 sağlıklı gönüllü alındı. Çalışma kapsamındaki hasta ve kontrol grubunun demografik bilgileri, kan basıncı değerleri, vücut kitle indeksi (VKİ), hematolojik ve biyokimyasal parametreler ve EDTA'lı tüplere alınan periferik kanda steril polimeraz zincir reaksiyonu yöntemi ile incelenen ACE gen polimorfizmi sonuçları kayıt edildi. Bulgular: Çalışmaya alınan hastaların 49'u HD, 38'i SAPD programında idi. Hasta grubunda erkek/kadın 48/39, yaş ortalaması 41.1±13.6 iken, kontrol grubunda 14/24 ve 38.0+1.41 idi. Hasta grubunda SDBY nedenleri olarak %28 diyabet, %24 hipertansiyon, %23 kronik glomerü-lonefrit ilk üç sırayı almaktaydı. Sistolik kan basıncı vediyastolik kan basıncı, hasta grubunda, kontrol grubuna göre daha yüksek bulundu. ACE gen (l/D) polimorfizmi prevalansı hasta grubunda, I l/l D/D D için sırasıyla %0.9, %44.8, %45.9; kontrol grubunda ise %31.5, %39.4, %28.9 bulundu ve istatistiksel farklılık tespit edildi (p-0.006!. Hasta grubu ve kontrol grubu ACE D allel dağılımları açısından hasta grubunda %68.4, kontrol grubunda %48.7 olarak bulundu (p=0.0Ü1). Sonuç: SDBY hasta popülasyonunda ACE genotip dağılımı ve D allel sıklığında kontrol grubundan farklılık tespit ettik.
FULL TEXT (PDF): 
PDF icon arastrmx_172977_16_pp_68-72.pdf
  • 2
68-72
  • Turkish

REFERENCES

References: 

1. Asakirnori v. Yorioka N, Yamamoto i, d aL Endothelial nit-rlc oxide synihase intron ı |>olyniorphism influences the progression of renal disease Nephron 2001;89<2):219-23-
2. Sakka Y, Babazono T, Sam A, el al. ACE gene polymorphism, left ventricular geometry, .mil mortality in diabetic patients willt end-stage renal disease Dİabete) Kes Clin Pracl 2004; Ml I ); 11-9.
•>. l.ovati E, Richard A, I'rey HM. Erey F|, Ferrari P. Genetic polymorphisms of the renin-angioicnsin-aldosterone system in end-stage renal disease. Kidney Int 2001;6()( 1 >:46-54. i. Wong TV, Szeto CC Chow KM. Chan JC, l.i PK. Contribulion ol gene potymurpbisai in the renin-angiotensin system to macroangiopalhy in patients with diabetic nephropathy. Am J Kklney Db 2:5l3-9.
0. Ekmekçi A. Canberk A. licrkman K. Angiotensinler, angii nensin reseptörleri vc angiotensin aniagonistlcri. Ekmekçi A. Canberk A. Bertunan K, editors. Istanbul. Park Matbaacılık; 2000.
7, Aros C, Remuzzl G. The renin-angiotensin system in progression, remission and regression of chronic nephropathies. J Hypertens 2002 (supp[>;2D:s i5-S53.
H, liaııdin IÎ. lierard M, Carrier JL. Legrand Y, Drouet I.. Vascular origin determines angiotensin [-converting expression in endothelial cells. Endothelium 1997;5:73-84.
9. Prasad A. Narayanan S. Waclawiw MA, Epstein N, Quyyuml AA Hie insertion/deletion polymorphism of Ihe angiutensin-convening enzyme gene determines coronary vascular lone and nitric oxide activity..] Am Col] Cardiol 2000;36:1579-86.
10, Butler R, Morris Al>. Bunnell B, Slntthers Al). DD angioten-
sin-converiing enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension 1999;33:1164-8.
11. Evans AE, Poiıter O, Kee F, et al. Polymorphism of the angiotensin converting enzyme gene in subjects who die From coronary heart disease. QuartJ Med 1994;87:211-4.
12. Remuzzi G, Bertani T. Pathophysiology of progressive neph-ropaties. N Engl J Med 1998;339:1448-50.
13. Krolewski AS. Genelics of diabetic nephropathy: evidence for and minor gene effects. Kidney Int 1999;55:1982-96.
14. Schmidt S, Ritz E.Genetics of the renin-angiotensin system and renal disease: a progress repon. Curr Opin Nephrol Hypertens. 1997;6( 2): 146-51.
15. Nomura H, Koni [, Miehishita Y, Morise T. Takeda li. Angi-otensin-converting enzyme gene polymorphism in liaemodi-alysis patients. Lancet 1994;343 482.
16. Fujisawa T. Ikegami H, Kawaguchi Y. et al. Metaanalysis of association of insenion/delelion polymorphism of ACE gene with diabetic nephropathy and retinopathy, Dİabetologîa 1998;41:47-53.
17. Pfohl M, Frost D, et a]. Lack of association between the insertion/deletion polymorphism of the angiotensin-convefting-enzyme gene and diabetic nephropathy in IDDM patients. Horm Metab Res.l998;3<>(5):27(>-80.
18. Buraczynska M, Ksiazek P, Drop A, et al. Genetic: polymorphism of the renin angiotensin system in end stage renal diseases. Nephrol Dial Transplant. 2006;2it4>:979-«3.
19. Yoshida H. Kuriyama S, Atsumi Y, el al. Angiotensin 1 convening enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int. 1990;50<2):6S7-64.
20. Bloem LJ, Manatunga AK, Pratt JH. Racial difference in ihe relationship of an ACE gene polymorphism to serum ACE activity. Hypertension 1996;27:62-6.
21. Hsieh MC, Lin SR, Ilsieh TJ, e! al. Increased frequency of angiotensin converting enzyme DD genotype in patients with lip 2 diabetes in Taiwan. Nephrol Dial Transplani 20O0;15<7): 1008-13.
22. Bedir A, Arık N. Adam B. Kıltnc K, Gümüş T, GQnef E. Angiotensin converting enzyme gene polymorphism anil activity in Turkish paiients with essential hypertension. American Journal of Hypertension 1999;12:1038-43.
23. Araz M, Aynacıoğhı S, Aktaran S, Alasehirli li, Okan V. Association between polymorphism of the angiotensin I converting enzyme gene and hypertension in Turkish type II diabetic patients. Acta Medica 2001;44:29-32.
24. van der Sman-de Beer F, Verhagen C, Rombach SM, Boors-ma P, van ManenJG, KorevaarJC, van den Bogaard R. Bo-eschoten EW, Krediel R'F, Navis GJ, VandenbrouckeJP, Dek-ker FW; for the NECOSAD Study Group. ACE l/D polymorp-liism is associated witli mortality in a cohort study of patients starting with dialysis. Kidney Int 2005;f>8(5):2237-43.
25. Barley JA, Blackwood, N.D.Carter, et al. ACE insertion/deletion polymorphism: association with ethnic origin. J Hypertens 1994;12:955-7.
26. Rotimi C, Puras A, Cooper R. et al. Polymorphism of renin-angiotensin genes among Nigerians. Jamaicans and African Americans. Hypertension 1996;27:558-(i3.
27. Matsubara M. Suzuki M, Fujiwara T, et al. ACE I/D polymorphism and hypertension: ihe Ohasama study I Hypertens 2002;20:1121-26.

Thank you for copying data from http://www.arastirmax.com